State of Wisconsin Investment Board Portfolio holdings
AUM
$40.9B
This Quarter Return
+14.65%
1 Year Return
+24.31%
3 Year Return
+99.94%
5 Year Return
+177.86%
10 Year Return
+427.44%
AUM
$35.2B
AUM Growth
+$35.2B
(+15%)
Cap. Flow
+$434M
Cap. Flow
% of AUM
1.23%
Top 10 Holdings %
Top 10 Hldgs %
16.68%
Holding
1,608
New
67
Increased
852
Reduced
590
Closed
71
Top Buys
| 1 |
Walt Disney
DIS
|
$46.4M |
| 2 |
Elevance Health
ELV
|
$44.2M |
| 3 |
Procter & Gamble
PG
|
$41.9M |
| 4 |
PayPal
PYPL
|
$31.6M |
| 5 |
Zillow
ZG
|
$30.2M |
Top Sells
| 1 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
$115M |
| 2 |
DocuSign
DOCU
|
$99.2M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$75.3M |
| 4 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
$73M |
| 5 |
Bank of America
BAC
|
$39.6M |
Sector Composition
| 1 | Technology | 17.95% |
| 2 | Financials | 15.77% |
| 3 | Healthcare | 13.34% |
| 4 | Consumer Discretionary | 10.43% |
| 5 | Industrials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRTK
1451
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $226K | ﹤0.01% | 42,200 +9,700 | +30% | +$51.9K |
|
|
HCR
1452
DELISTED
Hi-Crush Inc. Common Stock
HCR
| $223K | ﹤0.01% | 50,000 | – | – |
|
1453
Nabors Industries
NBR
$543M
| $222K | ﹤0.01% | 64,677 -1,850 | -3% | -$6.35K |
|
|
PETX
1454
DELISTED
Aratana Therapeutics, Inc.
PETX
| $221K | ﹤0.01% | 61,300 +14,100 | +30% | +$50.8K |
|
1455
Pilgrim's Pride
PPC
$10.6B
| $220K | ﹤0.01% | 9,880 -360 | -4% | -$8.02K |
|
1456
Seaboard Corp
SEB
$3.81B
| $219K | ﹤0.01% | +51 | New | +$219K |
|
1457
Aclaris Therapeutics
ACRS
$209M
| $216K | ﹤0.01% | 36,000 +8,200 | +29% | +$49.2K |
|
1458
Crinetics Pharmaceuticals
CRNX
$2.92B
| $216K | ﹤0.01% | 9,500 +2,100 | +28% | +$47.7K |
|
|
ADMS
1459
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $210K | ﹤0.01% | 29,500 +6,800 | +30% | +$48.4K |
|
|
MRNS
1460
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $206K | ﹤0.01% | 49,200 +11,300 | +30% | +$47.3K |
|
1461
Garrett Motion
GTX
$2.62B
| $204K | ﹤0.01% | 13,844 -490 | -3% | -$7.22K |
|
|
MIK
1462
DELISTED
Michaels Stores, Inc
MIK
| $202K | ﹤0.01% | 17,731 -2,025 | -10% | -$23.1K |
|
|
FSTX
1463
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $198K | ﹤0.01% | 18,900 +4,400 | +30% | +$46.1K |
|
1464
CASI Pharmaceuticals
CASI
$35.8M
| $194K | ﹤0.01% | 67,500 +15,500 | +30% | +$44.5K |
|
1465
Seres Therapeutics
MCRB
$166M
| $190K | ﹤0.01% | 27,700 +6,400 | +30% | +$43.9K |
|
1466
Newell Brands
NWL
$2.48B
| $188K | ﹤0.01% | 12,236 -212,445 | -95% | -$3.26M |
|
|
TVTY
1467
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $188K | ﹤0.01% | +10,705 | New | +$188K |
|
1468
Cue Biopharma
CUE
$60M
| $186K | ﹤0.01% | 24,100 +5,600 | +30% | +$43.2K |
|
|
BLCM
1469
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $183K | ﹤0.01% | 54,200 +12,500 | +30% | +$42.2K |
|
|
LJPC
1470
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $183K | ﹤0.01% | 28,500 +6,500 | +30% | +$41.7K |
|
1471
Ocular Therapeutix
OCUL
$2.12B
| $177K | ﹤0.01% | 44,600 +10,200 | +30% | +$40.5K |
|
|
FTSV
1472
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $175K | ﹤0.01% | +10,800 | New | +$175K |
|
1473
Spyre Therapeutics
SYRE
$996M
| $174K | ﹤0.01% | 21,600 +4,900 | +29% | +$39.5K |
|
1474
Arbutus Biopharma
ABUS
$711M
| $169K | ﹤0.01% | 47,300 +10,900 | +30% | +$38.9K |
|
|
INSY
1475
DELISTED
Insys Therapeutics, Inc.
INSY
| $166K | ﹤0.01% | 36,000 +8,200 | +29% | +$37.8K |
|